InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Bonello William, Chairman & CEO. Director active across 1 company, notably Neogenomics INC. In total, 7 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €54k. History available since 24 November 2021. The latest transaction was disclosed on 28 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bonello William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
5,727 shares@ US$7.529.3% of flowCommon StockSEC:0001077183-22-000071:0
82,305 shares0Common StockSEC:0001077183-22-000056:0
3,209 shares@ US$18.2912.3% of flowCommon StockSEC:0001077183-22-000049:0
40,869 shares0Common StockSEC:0001077183-22-000040:0
21,400 shares0Common StockSEC:0001077183-21-000275:0
25,000 shares@ US$7.5237.8% of flowCommon StockSEC:0001077183-21-000254:0
25,000 shares@ US$8.0340.6% of flowCommon StockSEC:0001077183-21-000251:0
7 of 7 declarations
About Bonello William
Bonello William is Président-Directeur Général and Chief Financial Officer at Neogenomics INC. He reported 7 filings in total, and across the 7 recent filings covered, sales total 53973 EUR, between 2021-11-29 and 2022-05-02, with Levée d'options as the most common transaction nature.
